Development of multi-epitope vaccines targeting wild-typesequence p53 peptides
AB DeLeo, TL Whiteside - Expert review of vaccines, 2008 - Taylor & Francis
Loss of p53 tumor-suppressor function is the most common abnormality in human cancer,
which can result in enhanced presentation to immune cells of wild-type (wt)-sequence …
which can result in enhanced presentation to immune cells of wild-type (wt)-sequence …
Development of multi-epitope vaccines targeting wild-typesequence p53 peptides
AB DeLeo, TL Whiteside - Expert Review of Vaccines, 2008 - go.gale.com
The development of therapeutic anticancer vaccines is based on the premise that tumors
express MHC allele-restricted epitopes that are antigenic, can be recognized by the host's …
express MHC allele-restricted epitopes that are antigenic, can be recognized by the host's …
Development of multi-epitope vaccines targeting wild-type sequence p53 peptides.
AB DeLeo, TL Whiteside - Expert Review of Vaccines, 2008 - europepmc.org
Loss of p53 tumor suppressor function is the most common abnormality in human cancer,
which can result in enhanced presentation to immune cells of wild type sequence (wt) …
which can result in enhanced presentation to immune cells of wild type sequence (wt) …
Development of multi-epitope vaccines targeting wild-type sequence p53 peptides
AB DeLeo, TL Whiteside - Expert review of vaccines, 2008 - pubmed.ncbi.nlm.nih.gov
Loss of p53 tumor-suppressor function is the most common abnormality in human cancer,
which can result in enhanced presentation to immune cells of wild-type (wt)-sequence …
which can result in enhanced presentation to immune cells of wild-type (wt)-sequence …
Development of multi-epitope vaccines targeting wild-typesequence p53 peptides
AB DeLeo, TL Whiteside - Expert Review of Vaccines, 2008 - search.proquest.com
Loss of p53 tumor-suppressor function is the most common abnormality in human cancer,
which can result in enhanced presentation to immune cells of wild-type (wt)-sequence …
which can result in enhanced presentation to immune cells of wild-type (wt)-sequence …
[HTML][HTML] Development of multi-epitope vaccines targeting wild-type (wt) sequence p53 peptides
AB DeLeo, TL Whiteside - Expert review of vaccines, 2008 - ncbi.nlm.nih.gov
Loss of p53 tumor suppressor function is the most common abnormality in human cancer,
which can result in enhanced presentation to immune cells of wild type sequence (wt) …
which can result in enhanced presentation to immune cells of wild type sequence (wt) …
Development of multi-epitope vaccines targeting wild-type sequence p53 peptides.
AB DeLeo, TL Whiteside - Expert Review of Vaccines, 2008 - europepmc.org
Loss of p53 tumor suppressor function is the most common abnormality in human cancer,
which can result in enhanced presentation to immune cells of wild type sequence (wt) …
which can result in enhanced presentation to immune cells of wild type sequence (wt) …